Aims/hypothesis Vitamin D deficiency during the fetal period or infancy is one of the suggested environmental factors for type 1 diabetes and for its increasing incidence. To test this hypothesis we compared serum 25-hydroxyvitamin D (25(OH)D) levels during early pregnancy in mothers of children who subsequently developed type 1 diabetes (case mothers) with mothers of non-diabetic healthy children (control mothers) of the same age. Methods Children with type 1 diabetes were identified from the nationwide prescription register. 25(OH)D concentration was measured from serum samples collected during the first trimester of pregnancy from all Finnish women (Finnish Maternity Cohort). A total of 343 case mothers and 343 control mothers were included in the study. Samples were collected throughout the year. Samples from case and control mothers were matched on the day of collection. Results Mean 25(OH)D levels in case mothers (43.9 nmol/l) and control mothers (43.7 nmol/l) were not different. Of all mothers, 481 (70.1%) were vitamin D-deficient or -insufficient. Conclusions/interpretation No difference was found in serum 25(OH)D concentrations during first trimester of pregnancy between mothers whose children later on developed type 1 diabetes, and mothers of non-diabetic ' healthy' children of the same age. It is difficult to detect possible effects of mothers' vitamin D deficiency during early pregnancy on the development of type 1 diabetes in the offspring in this population, as such a large proportion of mothers were vitamin D-deficient or -insufficient.
Introduction
Vitamin D deficiency during the fetal period or infancy is one of the suggested environmental factors for type 1 diabetes and for its increasing incidence [1] . In Finland, located in the north and where type 1 diabetes incidence is the highest in the world [2] , vitamin D deficiency has been shown to be common especially during the winter [3] .
Vitamin D supplementation during infancy has been associated with decreased risk of type 1 diabetes in several studies [4] [5] [6] , whereas in other studies no connection has been found between vitamin D supplementation [7] or intake [8] and type 1 diabetes. Some evidence has also been reported for an association between vitamin D supplementation during pregnancy and a decreased risk of type 1 diabetes [9] , or reduced development of beta cell-specific autoantibodies [7] in the offspring. In other studies, however, no association was seen between maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity [10] or type 1 diabetes [6] in the offspring. In these studies, vitamin D status was estimated from calculated supply from the diet and vitamin D supplements, without information on serum vitamin D levels. and >75 nmol/l as an optimal vitamin D level [13] . In a recent study by Simpson et al [8] , 25(OH)D level of children at increased risk of developing type 1 diabetes was not associated with islet autoimmunity or progression of type 1 diabetes. Thus far no study has investigated association of serum 25(OH)D levels during pregnancy with risk of type 1 diabetes in the offspring.
The aim of this study was to compare serum 25(OH)D levels during the first trimester of pregnancy of mothers of children with type 1 diabetes (case mothers) with those of mothers of healthy children (control mothers) of the same age. We also studied the differences in proportions of case and control mothers with vitamin D deficiency, insufficiency, sufficiency and optimal levels of vitamin D.
Methods
Since 1983, serum samples have been collected from all pregnant women in Finland during the first trimester of pregnancy (the Finnish Maternity Cohort; FMC). The FMC stores serum samples (at −20°C) from each pregnancy from almost all (98%) pregnant women in Finland. A sample of the serum is kept frozen for future use.
Initially, 751 case mothers were invited to participate in this study, of whom 498 (66.3%) participated. Mothers were obtained from the Finnish Diabetes Register for children; this database has been described in detail elsewhere [14] .
For each case mother, a corresponding control mother was selected according to the arrival of the serum samples in the FMC repository, with the case and control samples being collected on the same day. A control mother was invited to participate for each case mother, resulting in 343 casecontrol pairs. Where available, samples were collected from mothers during pregnancy of healthy siblings of the type 1 diabetes children, resulting in 137 samples from siblings. The mean duration of storage of the serum samples before the present vitamin D assay was 14.7 years (range 10-17 years).
The mean age at diagnosis of children with type 1 diabetes was 3.4 years (range 0-7 years). Informed consent was collected from all mothers, and the ethics committee of the Hospital District of Helsinki and Uusimaa approved the protocol.
Serum 25(OH)D was measured using an enzyme immunoassay method with IDS OCTEIA 25-Hydroxy vitamin D kit (Immunodiagnostic Systems, Boldon, UK). The intra-and inter-assay CVs were 3.57% and 3.68%, respectively. The analytical reliability of the 25(OH)D assay was assured by participation in the vitamin D External Quality Assessment Scheme (DEQAS; Charing Cross Hospital, London UK).
25(OH)D concentrations were compared using Student's t test. The differences in proportions of case and control mothers in the different vitamin D level groups were identified using Pearson's χ 2 test; p values <0.05 were considered statistically significant. Analyses were performed using PASW statistics 18 for Windows. As the time of sample collection was different in the siblings, season-standardised 
Results
The mean 25(OH)D level of the case mothers during pregnancy was 43.9 nmol/l (n0343; SD 16.9), and of the control mothers 43.5 nmol/l (n0343; SD 16.6; p00.70).
For case mothers who had serum samples available from both the pregnancies of a type 1 diabetic child, and of a nondiabetic sibling (n0137), the mean 25(OH)D level (using a correction factor i.e. season-standardised mean) during pregnancy of the type 1 diabetic child was 44.7 nmol/l, and during pregnancy of the non-diabetic healthy child 44.1 nmol/l (p00.60).
The proportions of mothers with vitamin D deficiency (<25 nmol/l), insufficiency (25-49 nmol/l), sufficiency (50-75 nmol/l) and optimal vitamin D status (>75 nmol/l) during pregnancy did not differ between the case and control mothers (p00.88; Fig. 1 ).
Association of serum 25(OH)D level during pregnancy with the onset age of type 1 diabetes was analysed. There was no difference between children with onset of type 1 diabetes at the age of 0-3 years (44.0 nmol/l; n0177) and 4-7 years (43.9 nmol/l; n0154; p00.96).
Discussion
We evaluated whether vitamin D status during the first trimester of pregnancy was associated with the risk of type 1 diabetes in the offspring. We compared serum 25(OH)D levels during pregnancy in mothers of children who later developed type 1 diabetes (case mothers) with levels in mothers of healthy children (control mothers). No difference was seen between the mean 25(OH)D levels of the case and control mothers. Neither was there any difference in serum 25(OH)D levels during pregnancy in women with type 1 diabetic children and other pregnancies of healthy siblings.
The present study includes a unique sample set, which gave us an opportunity to analyse vitamin D status during pregnancy retrospectively, when it was already known which of the children later developed type 1 diabetes. As serum samples were collected nationwide from all pregnancies, both recruitment and participation bias are excluded. In contrast to most previous studies of the putative connection of vitamin D with type 1 diabetes [4-6, 8, 9] , we were able to measure the actual serum 25(OH)D level, which is a total result of all vitamin D supply from diet, sunlight and supplements.
Serum 25(OH)D concentration is known to vary according to season due to differences in the amount of sunlight. To avoid bias, we matched the sera of case and control mothers so that the samples were collected on the same day. However, there is a possibility that in spite of the chemical stability of 25 (OH)D, some degradation occurred during storage. But as the samples from the case and control mothers were collected on the same day and stored in the same freezer, any potential degradation of 25(OH)D should be approximately the same in the case and control samples. A considerable proportion of pregnant Finnish women in this study had serum 25(OH)D levels below optimal during the first trimester of pregnancy. To evaluate the possible degradation of 25(OH)D during storage, we compared samples that had been stored for 10-13 and 14-17 years and found no difference in mean 25(OH) D concentrations. In another study using more recently collected FMC serum samples (less than 2 years before the analysis) [15] , the mean 25(OH)D concentration was lower (41.0 nmol/l) than in the present study, where the samples had been stored and analysed by the same method in the same laboratory.
A limitation of the present study is that samples were collected only during the first trimester of pregnancy. In another study [15] , the 25(OH)D levels of Finnish women were somewhat higher postpartum than during the first trimester of pregnancy, possibly indicating that an increased number of women use recommended vitamin D supplements during the last trimester than during the first trimester of pregnancy.
Our results indicate that it is unlikely that a relative vitamin D deficiency in pregnant women during early pregnancy contributes to the development of type 1 diabetes in the child. However, as a large proportion of the women studied had vitamin D deficiency or insufficiency, it is difficult to see the possible effect of vitamin D deficiency in the development of type 1 diabetes in the offspring. Thus, we cannot exclude the possibility that vitamin D deficiency acts as a risk-modifying factor only in those individuals who have a genetic susceptibility to type 1 diabetes. In addition, we cannot exclude the possibility that vitamin D deficiency may contribute to the high incidence of type 1 diabetes in Finnish children, although it may not be the main contributing factor.
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